MERCATELLI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 1.311
EU - Europa 278
AS - Asia 254
SA - Sud America 2
Totale 1.845
Nazione #
US - Stati Uniti d'America 1.302
CN - Cina 99
IT - Italia 93
SG - Singapore 80
GB - Regno Unito 38
TR - Turchia 38
DE - Germania 29
ID - Indonesia 26
AT - Austria 22
FI - Finlandia 22
UA - Ucraina 22
SE - Svezia 20
BE - Belgio 11
CA - Canada 9
PL - Polonia 7
FR - Francia 4
LT - Lituania 3
NL - Olanda 3
VN - Vietnam 3
IQ - Iraq 2
RO - Romania 2
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
IE - Irlanda 1
IN - India 1
IR - Iran 1
JP - Giappone 1
KZ - Kazakistan 1
PH - Filippine 1
TW - Taiwan 1
Totale 1.845
Città #
Fairfield 167
Woodbridge 157
Chandler 133
Ashburn 110
Houston 106
Santa Clara 85
Ann Arbor 81
Singapore 71
Wilmington 67
Seattle 66
Cambridge 58
Beijing 38
Jacksonville 35
Ferrara 30
Jakarta 26
Milan 22
Princeton 22
Vienna 22
Izmir 20
Boardman 15
Shanghai 15
Brussels 11
Lappeenranta 10
Nanjing 10
Frankfurt am Main 9
Los Angeles 9
Morciano Di Romagna 7
San Diego 7
Nanchang 6
Shenyang 6
Warsaw 6
Helsinki 5
London 5
Norwalk 5
Toronto 5
Auburn Hills 4
Bremen 4
Ottawa 4
Changsha 3
Dong Ket 3
Ferrara di Monte Baldo 3
Addison 2
Des Moines 2
Kunming 2
Monterenzio 2
Muggia 2
Ningbo 2
Orange 2
Pisa 2
Tappahannock 2
Zhengzhou 2
Almaty 1
Ardabil 1
Atlanta 1
Baghdad 1
Balasore 1
Basra 1
Bordeaux 1
Canda 1
Chiswick 1
Clearwater 1
Dublin 1
Edinburgh 1
Falls Church 1
Florence 1
Haikou 1
Hebei 1
Hounslow 1
Istanbul 1
Jiaxing 1
Manila 1
Newark 1
Pamplona 1
Philadelphia 1
Piscataway 1
Prescot 1
Qiqihar 1
Quito 1
Redwood City 1
Sanayi 1
Taipei 1
Taiyuan 1
Tianjin 1
Washington 1
Totale 1.521
Nome #
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity 202
Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells 173
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 160
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists 153
Knock-in mice with NOP-eGFP receptors identify receptor cellular and regional localization 115
AT-1001: A high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology 114
N/OFQ system in brain areas of nerve-injured mice: its role in different aspects of neuropathic pain 108
Parkinson's disease: no NOP, new hope 99
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4 96
NOP receptor ligands and Parkinson’s disease 91
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes 88
Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling 74
Managing Parkinson's disease: moving ON with NOP 72
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 55
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models 48
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity 47
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 44
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice 41
Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo 36
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia 34
Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse 31
Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model 24
Totale 1.905
Categoria #
all - tutte 12.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 575
Totale 12.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020285 0 0 0 0 0 70 40 42 51 25 41 16
2020/2021261 17 29 6 12 26 10 16 36 10 37 35 27
2021/2022172 3 15 6 2 6 21 18 12 5 19 25 40
2022/2023299 23 49 11 44 42 30 25 19 29 0 17 10
2023/2024149 18 13 6 9 11 17 7 13 3 11 1 40
2024/2025262 11 17 55 8 73 98 0 0 0 0 0 0
Totale 1.905